BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma
- 1 January 2015
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 51 (1) , 64-70
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81302352, 81372901)
This publication has 27 references indexed in Scilit:
- Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancersOral Oncology, 2014
- Brain-Derived Neurotrophic Factor (BDNF)-Induced Tropomyosin-Related Kinase B (Trk B) Signaling Is a Potential Therapeutic Target for Peritoneal Carcinomatosis Arising from Colorectal CancerPLOS ONE, 2014
- Molecular mechanisms of epithelial–mesenchymal transitionNature Reviews Molecular Cell Biology, 2014
- Adenoid cystic carcinoma of the head and neck: A single-center analysis of 105 consecutive cases over a 30-year periodOral Oncology, 2013
- Adenoid Cystic Carcinoma: Clinical and Molecular FeaturesHead and Neck Pathology, 2013
- TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinomaLung Cancer, 2013
- Contribution of cells undergoing epithelial–mesenchymal transition to the tumour microenvironmentJournal of Proteomics, 2012
- High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cellsJournal of Gastroenterology, 2012
- Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese populationInternational Journal of Oral and Maxillofacial Surgery, 2010
- TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinomaOncogene, 2010